Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 13 04:00PM ET
6.49
Dollar change
-0.20
Percentage change
-2.99
%
IndexRUT P/E- EPS (ttm)-0.29 Insider Own3.75% Shs Outstand232.45M Perf Week-3.71%
Market Cap1.52B Forward P/E44.96 EPS next Y0.14 Insider Trans-12.85% Shs Float225.21M Perf Month-16.69%
Income-65.81M PEG- EPS next Q-0.11 Inst Own61.11% Short Float13.74% Perf Quarter-19.18%
Sales159.11M P/S9.54 EPS this Y-14.13% Inst Trans50.96% Short Ratio5.99 Perf Half Y23.62%
Book/sh0.64 P/B10.06 EPS next Y142.16% ROA-23.53% Short Interest30.94M Perf Year59.85%
Cash/sh0.87 P/C7.50 EPS next 5Y30.00% ROE-47.64% 52W Range3.16 - 10.13 Perf YTD4.68%
Dividend Est.- P/FCF- EPS past 5Y28.61% ROI-26.17% 52W High-35.93% Beta0.81
Dividend TTM- Quick Ratio4.36 Sales past 5Y146.90% Gross Margin83.09% 52W Low105.38% ATR (14)0.37
Dividend Ex-Date- Current Ratio4.53 EPS Y/Y TTM27.62% Oper. Margin-38.90% RSI (14)39.86 Volatility4.66% 4.53%
Employees267 Debt/Eq0.70 Sales Y/Y TTM152.32% Profit Margin-41.36% Recom1.00 Target Price13.94
Option/ShortYes / Yes LT Debt/Eq0.67 EPS Q/Q11.99% Payout- Rel Volume0.61 Prev Close6.69
Sales Surprise26.44% EPS Surprise25.37% Sales Q/Q304.81% EarningsMay 02 AMC Avg Volume5.16M Price6.49
SMA20-8.69% SMA50-9.56% SMA2001.29% Trades Volume3,139,682 Change-2.99%
Date Action Analyst Rating Change Price Target Change
Apr-05-24Initiated Leerink Partners Outperform $14
Dec-18-23Initiated Raymond James Strong Buy $12
Sep-07-23Initiated H.C. Wainwright Buy $9
Aug-25-23Upgrade Cantor Fitzgerald Neutral → Overweight $5 → $10
Mar-03-23Upgrade Wedbush Neutral → Outperform $3 → $6
Nov-17-22Upgrade Piper Sandler Neutral → Overweight $3 → $8
May-06-22Downgrade Cantor Fitzgerald Overweight → Neutral $7 → $1
Dec-01-21Upgrade Ladenburg Thalmann Neutral → Buy $6
Oct-14-21Downgrade Ladenburg Thalmann Buy → Neutral
Jul-21-21Downgrade Jefferies Buy → Hold $11 → $2
May-30-24 04:02PM
03:30PM
May-22-24 08:02AM
May-21-24 08:02AM
May-19-24 04:00PM
08:01AM Loading…
May-16-24 08:01AM
May-15-24 04:30PM
May-14-24 04:02PM
May-09-24 04:43PM
May-07-24 05:00PM
08:01AM
May-04-24 11:00AM
May-03-24 02:16PM
09:57AM
07:31AM
06:21AM Loading…
06:21AM
May-02-24 08:58PM
05:45PM
04:47PM
04:02PM
May-01-24 08:00AM
Apr-25-24 10:02AM
Apr-18-24 08:00AM
Apr-02-24 11:34AM
Mar-28-24 04:05PM
Mar-25-24 08:00AM
Mar-16-24 06:00PM
Mar-12-24 04:35PM
Feb-28-24 05:40PM
Feb-27-24 08:00AM
06:10AM Loading…
06:10AM
Feb-23-24 10:16AM
Feb-22-24 06:00PM
05:15PM
04:45PM
04:26PM
04:01PM
Feb-19-24 03:30PM
12:24PM
Feb-15-24 10:00AM
Feb-09-24 09:55AM
08:50AM
Feb-08-24 12:16PM
12:00PM
09:40AM
Feb-07-24 09:34AM
Feb-06-24 04:00PM
Feb-02-24 02:15AM
Feb-01-24 08:00AM
Jan-29-24 12:35PM
Jan-12-24 07:56AM
Jan-10-24 02:27PM
Jan-08-24 08:00AM
Jan-03-24 08:03AM
Dec-29-23 11:01PM
Dec-20-23 08:00AM
Dec-14-23 06:40AM
Dec-05-23 09:11AM
Nov-21-23 04:02PM
09:37AM
08:01AM
Nov-17-23 09:00AM
Nov-15-23 04:02PM
Nov-13-23 04:02PM
Nov-10-23 08:05AM
Nov-06-23 08:00AM
Nov-03-23 08:00AM
Nov-02-23 09:40AM
Nov-01-23 10:42AM
Oct-31-23 11:15PM
05:09PM
08:40AM
07:29AM
07:00AM
Oct-30-23 05:42PM
Oct-23-23 08:07AM
Oct-19-23 10:21AM
Oct-18-23 04:31PM
04:02PM
10:42AM
Oct-17-23 07:24PM
07:23PM
07:06PM
07:01PM
Oct-13-23 08:00AM
Oct-11-23 04:17PM
Oct-04-23 08:00AM
Sep-28-23 08:02AM
Sep-25-23 04:15AM
Sep-17-23 10:54AM
Sep-12-23 09:12AM
Sep-11-23 08:00AM
Sep-08-23 08:00AM
Sep-07-23 08:00AM
Sep-06-23 12:36PM
12:13PM
Aug-30-23 01:02PM
Aug-28-23 10:22AM
Aug-26-23 03:17PM
Aug-25-23 09:42AM
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams Laura AChief Medical OfficerJun 05 '24Option Exercise2.75100,000275,000467,152Jun 07 06:29 PM
Williams Laura AChief Medical OfficerJun 05 '24Sale7.12145,0001,033,080322,152Jun 07 06:29 PM
Rosenbaum David P.Chief Development OfficerJun 03 '24Sale7.0017,872125,104158,502Jun 05 08:00 PM
RAAB MICHAELPresident & CEOMay 29 '24Sale6.727,50050,3901,270,273May 31 04:31 PM
RAAB MICHAELPresident & CEOMay 21 '24Sale7.8131,484245,9221,277,773May 23 04:13 PM
GRAMMER ELIZABETH ASee RemarksMay 21 '24Sale7.816,92754,107199,469May 23 04:10 PM
Rodriguez SusanChief Commercial OfficerMay 21 '24Sale7.816,70352,357449,092May 23 04:17 PM
Renz Justin AChief Financial OfficerMay 21 '24Sale7.815,16740,359300,546May 23 04:15 PM
Rosenbaum David P.Chief Development OfficerMay 21 '24Sale7.814,85537,922376,479May 23 04:19 PM
Blanks RobertSee RemarksMay 21 '24Sale7.814,85537,922362,331May 23 04:07 PM
Williams Laura AChief Medical OfficerMay 21 '24Sale7.814,79437,446367,152May 23 04:21 PM
Felsch Robert OraSee RemarksMay 21 '24Sale7.813,48527,22195,127May 23 04:08 PM
Rosenbaum David P.Chief Development OfficerMay 21 '24Sale7.812,19817,169176,374May 23 04:19 PM
RAAB MICHAELPresident & CEOMay 14 '24Sale7.993,00023,9701,307,933May 15 06:15 PM
GRAMMER ELIZABETH ASee RemarksMay 06 '24Option Exercise1.87219,937410,787487,930May 09 04:03 PM
Felsch Robert OraSee RemarksMay 06 '24Option Exercise1.48119,101176,445303,935May 09 04:03 PM
GRAMMER ELIZABETH ASee RemarksMay 06 '24Sale8.88284,1702,522,217203,760May 09 04:03 PM
Felsch Robert OraSee RemarksMay 06 '24Sale8.81207,9881,831,50395,947May 09 04:03 PM
Williams Laura AChief Medical OfficerMay 03 '24Option Exercise0.9930,00029,700410,138May 07 04:48 PM
GRAMMER ELIZABETH ASee RemarksMay 03 '24Sale9.0045,000405,000267,993May 07 06:24 PM
Williams Laura AChief Medical OfficerMay 03 '24Sale8.3539,949333,574370,189May 07 04:48 PM
RAAB MICHAELPresident & CEOApr 29 '24Option Exercise0.9930,00029,7001,340,933May 01 07:59 PM
RAAB MICHAELPresident & CEOApr 29 '24Sale6.4030,000192,0571,310,933May 01 07:59 PM
RAAB MICHAELPresident & CEOApr 15 '24Sale7.067,50052,9241,310,933Apr 17 04:20 PM
RAAB MICHAELPresident & CEOApr 01 '24Sale7.311,51811,0971,318,433Apr 02 04:05 PM
GRAMMER ELIZABETH ASee RemarksMar 20 '24Sale7.7386,000664,978312,993Mar 22 04:42 PM
Rosenbaum David P.Chief Development OfficerFeb 26 '24Sale9.205,18347,684175,936Feb 28 06:57 PM
RAAB MICHAELPresident & CEOFeb 20 '24Sale8.7522,917200,4391,319,951Feb 22 04:58 PM
Rodriguez SusanChief Commercial OfficerFeb 20 '24Sale8.756,92860,594452,795Feb 22 04:56 PM
Renz Justin AChief Financial OfficerFeb 20 '24Sale8.755,34146,714304,835Feb 22 05:01 PM
Blanks RobertSee RemarksFeb 20 '24Sale8.755,01743,880368,186Feb 22 04:58 PM
Rosenbaum David P.Chief Development OfficerFeb 20 '24Sale8.755,01743,880378,985Feb 22 06:30 PM
Williams Laura AChief Medical OfficerFeb 20 '24Sale8.754,80342,008380,138Feb 22 04:56 PM
GRAMMER ELIZABETH ASee RemarksFeb 20 '24Sale8.754,43238,764398,993Feb 22 04:57 PM
Felsch Robert OraSee RemarksFeb 20 '24Sale8.752,35220,571184,834Feb 22 04:56 PM
Rosenbaum David P.Chief Development OfficerFeb 20 '24Sale8.752,29420,064181,119Feb 22 06:30 PM
Rosenbaum David P.Chief Development OfficerFeb 08 '24Sale9.1815,344140,846384,002Feb 09 04:14 PM
Rosenbaum David P.Chief Development OfficerJan 08 '24Sale6.6430,000199,200286,596Jan 10 05:36 PM
Renz Justin AChief Financial OfficerDec 26 '23Option Exercise0.9975,00074,250407,426Dec 28 05:44 PM
Renz Justin AChief Financial OfficerDec 26 '23Sale6.36225,0001,430,122182,426Dec 28 05:44 PM
Rosenbaum David P.Chief Development OfficerDec 18 '23Sale6.075,67534,447316,596Dec 20 04:49 PM
Rosenbaum David P.Chief Development OfficerDec 14 '23Sale5.557,00038,850322,271Dec 15 06:13 PM
GRAMMER ELIZABETH ASee RemarksDec 11 '23Sale5.0850,000253,925275,675Dec 13 05:44 PM
Rosenbaum David P.Chief Development OfficerDec 08 '23Sale5.2720,000105,476329,271Dec 08 05:58 PM
Rosenbaum David P.Chief Development OfficerDec 05 '23Sale5.0010,27251,360349,271Dec 06 04:49 PM
Rosenbaum David P.Chief Development OfficerNov 30 '23Sale4.503,00013,500359,543Dec 01 04:47 PM
RAAB MICHAELPresident & CEONov 20 '23Sale4.3611,36849,589867,868Nov 22 05:19 PM
Rodriguez SusanChief Commercial OfficerNov 20 '23Sale4.364,71420,563346,973Nov 22 05:20 PM
Renz Justin AChief Financial OfficerNov 20 '23Sale4.362,87312,533332,426Nov 22 05:20 PM
Blanks RobertSee RemarksNov 20 '23Sale4.362,83512,367260,453Nov 22 05:17 PM
Rosenbaum David P.Chief Development OfficerNov 20 '23Sale4.362,83512,367362,543Nov 22 05:21 PM
Williams Laura AChief Medical OfficerNov 20 '23Sale4.362,58111,259266,191Nov 22 05:22 PM
GRAMMER ELIZABETH ASee RemarksNov 20 '23Sale4.362,38410,399325,675Nov 22 05:19 PM
Felsch Robert OraSee RemarksNov 20 '23Sale4.361,0444,554117,066Nov 22 05:18 PM
Rosenbaum David P.Chief Development OfficerNov 20 '23Sale4.369324,066113,293Nov 22 05:21 PM
Williams Laura AChief Medical OfficerNov 15 '23Sale4.0025,00099,998266,839Nov 17 05:30 PM
Rosenbaum David P.Chief Development OfficerOct 10 '23Sale4.001,6446,576365,378Oct 12 05:09 PM
Rosenbaum David P.Chief Development OfficerSep 08 '23Sale4.552,89713,181367,022Sep 12 05:24 PM
RAAB MICHAELPresident & CEOAug 21 '23Sale3.5511,41940,558876,236Aug 23 04:41 PM
Rodriguez SusanChief Commercial OfficerAug 21 '23Sale3.554,73316,811348,687Aug 23 04:48 PM
Renz Justin AChief Financial OfficerAug 21 '23Sale3.552,88410,243333,849Aug 23 04:42 PM
Rosenbaum David P.Chief Development OfficerAug 21 '23Sale3.552,84610,108369,919Aug 23 04:45 PM
Blanks RobertSee RemarksAug 21 '23Sale3.552,84610,108263,288Aug 23 04:36 PM
Williams Laura AChief Medical OfficerAug 21 '23Sale3.552,5919,203291,839Aug 23 04:46 PM
GRAMMER ELIZABETH ASee RemarksAug 21 '23Sale3.552,3928,496328,059Aug 23 04:39 PM
Felsch Robert OraSee RemarksAug 21 '23Sale3.551,0483,722115,110Aug 23 04:38 PM
Rosenbaum David P.Chief Development OfficerAug 21 '23Sale3.559373,328111,225Aug 23 04:45 PM
Williams Laura AChief Medical OfficerJun 27 '23Sale3.3525,00083,632294,430Jun 29 07:22 PM
Blanks RobertSee RemarksJun 23 '23Option Exercise3.4233,333113,999299,467Jun 27 06:40 PM
Blanks RobertSee RemarksJun 23 '23Sale3.6333,333121,042266,134Jun 27 06:40 PM